Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Exclusion Criteria

• •Clinical Multiple Sclerosis relapse in the prior 1 year
• •Oral or IV steroids in the prior 3 months
• •Have taken LA in last 30 days
• •Clinically significant kidney disease as determined by the PI including, but not limited to, major kidney disease diagnoses, abnormal laboratory values related to renal function, or other related conditions
• •Insulin-dependent diabetes
• •Other significant ongoing medical illness that may interfere with study procedures
• •Taking oral anticoagulants (e.g. Coumadin). Aspirin, clopidogrel, and dipyridamole are acceptable to take
• •Pregnant or breast-feeding
• •Any condition which would make the patient, in the opinion of the investigator, unsuitable for the study